Tecogen 10-Q: Material Weakness Disclosed as Cash Falls 57% and Nine-Month Loss Widens
TGEN sits 51% above its 52-week low of $1.5 on elevated volume (10× avg).
Summary
Tecogen's Q3 10-Q confirms the 9.6% revenue growth already reported, but also discloses a material weakness in internal controls and a 57.1% drop in cash to $5.3M, with management flagging it may need to raise more capital.
Key Events · Earnings and Guidance · TGEN
-
Material Weakness in Internal Controls
Management concluded disclosure controls and procedures were not effective due to a material weakness involving a small number of individuals dealing with general controls over information technology; remediation is underway.
-
Cash Down 57.1% in Nine Months
Cash and cash equivalents fell to $5,333,436 at September 30, 2026 from $12,430,287 at December 31, 2025, a decrease of $7,096,851, driven by $6,846,543 used in operating activities.
-
Nine-Month Loss Widens to $5.86M
Net loss attributable to Tecogen was $5,858,744 versus $4,254,974 a year earlier, as product revenue fell 38.2% to $5,358,026 and operating expenses rose 13.3% to $13,561,980.
-
Q3 Revenue Up 9.6%, Margin Improves
Third-quarter revenue was $7,873,820 versus $7,183,121, and gross margin rose to 37.4% from 30.4%, narrowing the quarterly net loss to $1,589,568 from $2,130,947.
Analysis · TGEN · Technology
The headline Q3 numbers were already out in the same-day 8-K — revenue up 9.6% to $7.87M and gross margin up 7 points — but the 10-Q adds two items that release did not carry. First, management concluded disclosure controls and procedures were not effective because of a material weakness in general IT controls, a governance flag on a company that is already losing money. Second, the cash picture is tighter than the quarter alone suggests: cash fell $7.1M, or 57.1%, to $5.3M over nine months, and the company says it may need to raise more debt or equity to fund growth and the data center push. Against a $5.9M nine-month loss and an accumulated deficit of $61.7M, another raise would mean more dilution for holders.
How filings like this one have moved
In the 30 days to Nov 12, 2026, 47.3% of the 1873 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.17%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, TGEN was trading at $2.27 on NYSE in the Technology sector, with a market capitalization of approximately $68.5M. The 52-week trading range was $1.50 to $8.18. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.